The “and more” is the key. Opdivo has produced excellent data in many different cancer types and settings. If it were truly an inferior drug to Keytruda generally, we would presumably have seen other instances of that by now.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.